Notable
SARRE-COMS · Sustained Asthma Remission and Reduced Relapse Using a Comprehensive Management Strategy (SARRE-COMS)
Primary endpoint(s) modified
Also in this update: Primary completion moved earlier from Dec 31, 2028 to Oct 31, 2028; Study completion moved earlier from Mar 30, 2029 to Dec 30, 2028
Hana SerajeddiniNot applicable NCT07816718 Registry history of NCT07816718 on ClinicalTrials.gov (opens the registry)